APO Research
Talk to an analyst

APO RESEARCH · REPORT

Olaparib

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Olaparib Market Analysis and Forecast 2026-2032

23 December 2025198 pages

Choose your research edition.

Industry ResearchOlaparib Industry Research Report 2026108 pages · $2,950 USDIndustry Growth & TrendsGlobal Olaparib Industry Growth and Trends Forecast to 203277 pages · $3,450 USDMarket StructureGlobal Olaparib Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032170 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Olaparib Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Olaparib Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Olaparib market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Olaparib is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Olaparib is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Olaparib is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Olaparib is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Olaparib include AstraZeneca and Everest Pharmaceuticals etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Olaparib, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Olaparib, also provides the sales of main regions and countries. Of the upcoming market potential for Olaparib, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Olaparib sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Olaparib market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Olaparib sales, projected growth trends, production technology, application and end-user industry.

Olaparib Segment by Company

AstraZeneca

Everest Pharmaceuticals

Olaparib Segment by Type

Tablets

Capsules

Olaparib Segment by Application

Ovarian Cancers

Prostate Cancers

Breast Cancers

Others

Olaparib Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Olaparib market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Olaparib and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Olaparib.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Olaparib in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Olaparib manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Olaparib sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Olaparib Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Tablets Major Manufacturers Table 3. Capsules Major Manufacturers Table 4. Global Olaparib Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Ovarian Cancers Major Manufacturers Table 6. Prostate Cancers Major Manufacturers Table 7. Breast Cancers Major Manufacturers Table 8. Others Major Manufacturers Table 9. Olaparib Industry Trends Table 10. Olaparib Industry Drivers Table 11. Olaparib Industry Opportunities and Challenges Table 12. Olaparib Industry Restraints Table 13. Global Olaparib Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Olaparib Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Olaparib Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Olaparib Revenue Market Share by Region (2021-2026) Table 17. Global Olaparib Revenue Market Share by Region (2027-2032) Table 18. Global Olaparib Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k pcs) Table 19. Global Olaparib Sales by Region (2021-2026) & (k pcs) Table 20. Global Olaparib Sales by Region (2027-2032) & (k pcs) Table 21. Global Olaparib Sales Market Share by Region (2021-2026) Table 22. Global Olaparib Sales Market Share by Region (2027-2032) Table 23. Global Olaparib Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Olaparib Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Olaparib Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Olaparib Sales Market Share by Manufacturers (2021-2026) Table 27. Global Olaparib Sales Price (US$/pcs) of Manufacturers (2021-2026) Table 28. Global Olaparib Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Olaparib Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Olaparib Manufacturers, Product Type & Application Table 31. Global Olaparib Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Olaparib by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Olaparib Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Olaparib Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Olaparib Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Olaparib Revenue Market Share by Type (2021-2026) Table 38. Global Olaparib Revenue Market Share by Type (2027-2032) Table 39. Global Olaparib Sales by Type 2021 VS 2025 VS 2032 (k pcs) Table 40. Global Olaparib Sales by Type (2021-2026) & (k pcs) Table 41. Global Olaparib Sales by Type (2027-2032) & (k pcs) Table 42. Global Olaparib Sales Market Share by Type (2021-2026) Table 43. Global Olaparib Sales Market Share by Type (2027-2032) Table 44. Global Olaparib Price by Type (2021-2026) & (US$/pcs) Table 45. Global Olaparib Price by Type (2027-2032) & (US$/pcs) Table 46. Global Olaparib Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Olaparib Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Olaparib Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Olaparib Revenue Market Share by Application (2021-2026) Table 50. Global Olaparib Revenue Market Share by Application (2027-2032) Table 51. Global Olaparib Sales by Application 2021 VS 2025 VS 2032 (k pcs) Table 52. Global Olaparib Sales by Application (2021-2026) & (k pcs) Table 53. Global Olaparib Sales by Application (2027-2032) & (k pcs) Table 54. Global Olaparib Sales Market Share by Application (2021-2026) Table 55. Global Olaparib Sales Market Share by Application (2027-2032) Table 56. Global Olaparib Price by Application (2021-2026) & (US$/pcs) Table 57. Global Olaparib Price by Application (2027-2032) & (US$/pcs) Table 58. AstraZeneca Company Information Table 59. AstraZeneca Business Overview Table 60. AstraZeneca Olaparib Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 61. AstraZeneca Olaparib Product Portfolio Table 62. AstraZeneca Recent Development Table 63. Everest Pharmaceuticals Company Information Table 64. Everest Pharmaceuticals Business Overview Table 65. Everest Pharmaceuticals Olaparib Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 66. Everest Pharmaceuticals Olaparib Product Portfolio Table 67. Everest Pharmaceuticals Recent Development Table 68. North America Olaparib Revenue by Type (2021-2026) & (US$ Million) Table 69. North America Olaparib Revenue by Type (2027-2032) & (US$ Million) Table 70. North America Olaparib Sales by Type (2021-2026) & (k pcs) Table 71. North America Olaparib Sales by Type (2027-2032) & (k pcs) Table 72. North America Olaparib Sales Price by Type (2021-2026) & (US$/pcs) Table 73. North America Olaparib Sales Price by Type (2027-2032) & (US$/pcs) Table 74. North America Olaparib Revenue by Application (2021-2026) & (US$ Million) Table 75. North America Olaparib Revenue by Application (2027-2032) & (US$ Million) Table 76. North America Olaparib Sales by Application (2021-2026) & (k pcs) Table 77. North America Olaparib Sales by Application (2027-2032) & (k pcs) Table 78. North America Olaparib Sales Price by Application (2021-2026) & (US$/pcs) Table 79. North America Olaparib Sales Price by Application (2027-2032) & (US$/pcs) Table 80. North America Olaparib Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 81. North America Olaparib Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 82. North America Olaparib Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 83. North America Olaparib Sales by Country (2021 VS 2025 VS 2032) & (k pcs) Table 84. North America Olaparib Sales by Country (2021-2026) & (k pcs) Table 85. North America Olaparib Sales by Country (2027-2032) & (k pcs) Table 86. North America Olaparib Sales Price by Country (2021-2026) & (US$/pcs) Table 87. North America Olaparib Sales Price by Country (2027-2032) & (US$/pcs) Table 88. United States Olaparib Revenue (2021-2032) & (US$ Million) Table 89. Canada Olaparib Revenue (2021-2032) & (US$ Million) Table 90. Mexico Olaparib Revenue (2021-2032) & (US$ Million) Table 91. Europe Olaparib Revenue by Type (2021-2026) & (US$ Million) Table 92. Europe Olaparib Revenue by Type (2027-2032) & (US$ Million) Table 93. Europe Olaparib Sales by Type (2021-2026) & (k pcs) Table 94. Europe Olaparib Sales by Type (2027-2032) & (k pcs) Table 95. Europe Olaparib Sales Price by Type (2021-2026) & (US$/pcs) Table 96. Europe Olaparib Sales Price by Type (2027-2032) & (US$/pcs) Table 97. Europe Olaparib Revenue by Application (2021-2026) & (US$ Million) Table 98. Europe Olaparib Revenue by Application (2027-2032) & (US$ Million) Table 99. Europe Olaparib Sales by Application (2021-2026) & (k pcs) Table 100. Europe Olaparib Sales by Application (2027-2032) & (k pcs) Table 101. Europe Olaparib Sales Price by Application (2021-2026) & (US$/pcs) Table 102. Europe Olaparib Sales Price by Application (2027-2032) & (US$/pcs) Table 103. Europe Olaparib Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 104. Europe Olaparib Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 105. Europe Olaparib Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 106. Europe Olaparib Sales by Country (2021 VS 2025 VS 2032) & (k pcs) Table 107. Europe Olaparib Sales by Country (2021-2026) & (k pcs) Table 108. Europe Olaparib Sales by Country (2027-2032) & (k pcs) Table 109. Europe Olaparib Sales Price by Country (2021-2026) & (US$/pcs) Table 110. Europe Olaparib Sales Price by Country (2027-2032) & (US$/pcs) Table 111. Germany Olaparib Revenue (2021-2032) & (US$ Million) Table 112. France Olaparib Revenue (2021-2032) & (US$ Million) Table 113. U.K. Olaparib Revenue (2021-2032) & (US$ Million) Table 114. Italy Olaparib Revenue (2021-2032) & (US$ Million) Table 115. Russia Olaparib Revenue (2021-2032) & (US$ Million) Table 116. Spain Olaparib Revenue (2021-2032) & (US$ Million) Table 117. Netherlands Olaparib Revenue (2021-2032) & (US$ Million) Table 118. Switzerland Olaparib Revenue (2021-2032) & (US$ Million) Table 119. Sweden Olaparib Revenue (2021-2032) & (US$ Million) Table 120. Poland Olaparib Revenue (2021-2032) & (US$ Million) Table 121. China Olaparib Revenue by Type (2021-2026) & (US$ Million) Table 122. China Olaparib Revenue by Type (2027-2032) & (US$ Million) Table 123. China Olaparib Sales by Type (2021-2026) & (k pcs) Table 124. China Olaparib Sales by Type (2027-2032) & (k pcs) Table 125. China Olaparib Sales Price by Type (2021-2026) & (US$/pcs) Table 126. China Olaparib Sales Price by Type (2027-2032) & (US$/pcs) Table 127. China Olaparib Revenue by Application (2021-2026) & (US$ Million) Table 128. China Olaparib Revenue by Application (2027-2032) & (US$ Million) Table 129. China Olaparib Sales by Application (2021-2026) & (k pcs) Table 130. China Olaparib Sales by Application (2027-2032) & (k pcs) Table 131. China Olaparib Sales Price by Application (2021-2026) & (US$/pcs) Table 132. China Olaparib Sales Price by Application (2027-2032) & (US$/pcs) Table 133. Asia Olaparib Revenue by Type (2021-2026) & (US$ Million) Table 134. Asia Olaparib Revenue by Type (2027-2032) & (US$ Million) Table 135. Asia Olaparib Sales by Type (2021-2026) & (k pcs) Table 136. Asia Olaparib Sales by Type (2027-2032) & (k pcs) Table 137. Asia Olaparib Sales Price by Type (2021-2026) & (US$/pcs) Table 138. Asia Olaparib Sales Price by Type (2027-2032) & (US$/pcs) Table 139. Asia Olaparib Revenue by Application (2021-2026) & (US$ Million) Table 140. Asia Olaparib Revenue by Application (2027-2032) & (US$ Million) Table 141. Asia Olaparib Sales by Application (2021-2026) & (k pcs) Table 142. Asia Olaparib Sales by Application (2027-2032) & (k pcs) Table 143. Asia Olaparib Sales Price by Application (2021-2026) & (US$/pcs) Table 144. Asia Olaparib Sales Price by Application (2027-2032) & (US$/pcs) Table 145. Asia Olaparib Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 146. Asia Olaparib Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 147. Asia Olaparib Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 148. Asia Olaparib Sales by Country (2021 VS 2025 VS 2032) & (k pcs) Table 149. Asia Olaparib Sales by Country (2021-2026) & (k pcs) Table 150. Asia Olaparib Sales by Country (2027-2032) & (k pcs) Table 151. Asia Olaparib Sales Price by Country (2021-2026) & (US$/pcs) Table 152. Asia Olaparib Sales Price by Country (2027-2032) & (US$/pcs) Table 153. Japan Olaparib Revenue (2021-2032) & (US$ Million) Table 154. South Korea Olaparib Revenue (2021-2032) & (US$ Million) Table 155. India Olaparib Revenue (2021-2032) & (US$ Million) Table 156. Australia Olaparib Revenue (2021-2032) & (US$ Million) Table 157. Taiwan Olaparib Revenue (2021-2032) & (US$ Million) Table 158. Southeast Asia Olaparib Revenue (2021-2032) & (US$ Million) Table 159. SAMEA Olaparib Revenue by Type (2021-2026) & (US$ Million) Table 160. SAMEA Olaparib Revenue by Type (2027-2032) & (US$ Million) Table 161. SAMEA Olaparib Sales by Type (2021-2026) & (k pcs) Table 162. SAMEA Olaparib Sales by Type (2027-2032) & (k pcs) Table 163. SAMEA Olaparib Sales Price by Type (2021-2026) & (US$/pcs) Table 164. SAMEA Olaparib Sales Price by Type (2027-2032) & (US$/pcs) Table 165. SAMEA Olaparib Revenue by Application (2021-2026) & (US$ Million) Table 166. SAMEA Olaparib Revenue by Application (2027-2032) & (US$ Million) Table 167. SAMEA Olaparib Sales by Application (2021-2026) & (k pcs) Table 168. SAMEA Olaparib Sales by Application (2027-2032) & (k pcs) Table 169. SAMEA Olaparib Sales Price by Application (2021-2026) & (US$/pcs) Table 170. SAMEA Olaparib Sales Price by Application (2027-2032) & (US$/pcs) Table 171. SAMEA Olaparib Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 172. SAMEA Olaparib Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 173. SAMEA Olaparib Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 174. SAMEA Olaparib Sales by Country (2021 VS 2025 VS 2032) & (k pcs) Table 175. SAMEA Olaparib Sales by Country (2021-2026) & (k pcs) Table 176. SAMEA Olaparib Sales by Country (2027-2032) & (k pcs) Table 177. SAMEA Olaparib Sales Price by Country (2021-2026) & (US$/pcs) Table 178. SAMEA Olaparib Sales Price by Country (2027-2032) & (US$/pcs) Table 179. Brazil Olaparib Revenue (2021-2032) & (US$ Million) Table 180. Argentina Olaparib Revenue (2021-2032) & (US$ Million) Table 181. Chile Olaparib Revenue (2021-2032) & (US$ Million) Table 182. Colombia Olaparib Revenue (2021-2032) & (US$ Million) Table 183. Peru Olaparib Revenue (2021-2032) & (US$ Million) Table 184. Saudi Arabia Olaparib Revenue (2021-2032) & (US$ Million) Table 185. Israel Olaparib Revenue (2021-2032) & (US$ Million) Table 186. UAE Olaparib Revenue (2021-2032) & (US$ Million) Table 187. Turkey Olaparib Revenue (2021-2032) & (US$ Million) Table 188. Iran Olaparib Revenue (2021-2032) & (US$ Million) Table 189. Egypt Olaparib Revenue (2021-2032) & (US$ Million) Table 190. Key Raw Materials Table 191. Raw Materials Key Suppliers Table 192. Olaparib Distributors List Table 193. Olaparib Customers List Table 194. Research Programs/Design for This Report Table 195. Authors List of This Report Table 196. Secondary Sources Table 197. Primary Sources List of Figures Figure 1. Olaparib Image Figure 2. Global Olaparib Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Olaparib Market Size Share 2021 VS 2025 VS 2032 Figure 4. Tablets Image Figure 5. Capsules Image Figure 6. Global Olaparib Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Olaparib Market Size Share 2021 VS 2025 VS 2032 Figure 8. Ovarian Cancers Image Figure 9. Prostate Cancers Image Figure 10. Breast Cancers Image Figure 11. Others Image Figure 12. Global Olaparib Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Olaparib Revenue (2021-2032) & (US$ Million) Figure 14. Global Olaparib Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Olaparib Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Olaparib Revenue Market Share by Region (2021-2032) Figure 17. Global Olaparib Sales (2021-2032) & (k pcs) Figure 18. Global Olaparib Sales by Region: 2021 VS 2025 VS 2032 (k pcs) Figure 19. Global Olaparib Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Olaparib Sales YoY (2021-2032) & (k pcs) Figure 21. Europe Olaparib Sales YoY (2021-2032) & (k pcs) Figure 22. China Olaparib Sales YoY (2021-2032) & (k pcs) Figure 23. Asia (Excluding China) Olaparib Sales YoY (2021-2032) & (k pcs) Figure 24. South America, Middle East and Africa Olaparib Sales YoY (2021-2032) & (k pcs) Figure 25. Global Olaparib Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Olaparib Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Olaparib Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Olaparib Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Olaparib Revenue Market Share by Type (2021-2032) Figure 31. Global Olaparib Sales by Type (2021 VS 2025 VS 2032) & (k pcs) Figure 32. Global Olaparib Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Olaparib Sales Market Share by Type (2021-2032) Figure 34. Global Olaparib Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Olaparib Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Olaparib Revenue Market Share by Application (2021-2032) Figure 37. Global Olaparib Sales by Application (2021 VS 2025 VS 2032) & (k pcs) Figure 38. Global Olaparib Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Olaparib Sales Market Share by Application (2021-2032) Figure 40. North America Olaparib Revenue Share by Type (2021-2032) Figure 41. North America Olaparib Sales Share by Type (2021-2032) Figure 42. North America Olaparib Revenue Share by Application (2021-2032) Figure 43. North America Olaparib Sales Share by Application (2021-2032) Figure 44. North America Olaparib Revenue Share by Country (2021-2032) Figure 45. North America Olaparib Sales Share by Country (2021-2032) Figure 46. Europe Olaparib Revenue Share by Type (2021-2032) Figure 47. Europe Olaparib Sales Share by Type (2021-2032) Figure 48. Europe Olaparib Revenue Share by Application (2021-2032) Figure 49. Europe Olaparib Sales Share by Application (2021-2032) Figure 50. Europe Olaparib Revenue Share by Country (2021-2032) Figure 51. Europe Olaparib Sales Share by Country (2021-2032) Figure 52. China Olaparib Revenue Share by Type (2021-2032) Figure 53. China Olaparib Sales Share by Type (2021-2032) Figure 54. China Olaparib Revenue Share by Application (2021-2032) Figure 55. China Olaparib Sales Share by Application (2021-2032) Figure 56. Asia Olaparib Revenue Share by Type (2021-2032) Figure 57. Asia Olaparib Sales Share by Type (2021-2032) Figure 58. Asia Olaparib Revenue Share by Application (2021-2032) Figure 59. Asia Olaparib Sales Share by Application (2021-2032) Figure 60. Asia Olaparib Revenue Share by Country (2021-2032) Figure 61. Asia Olaparib Sales Share by Country (2021-2032) Figure 62. SAMEA Olaparib Revenue Share by Type (2021-2032) Figure 63. SAMEA Olaparib Sales Share by Type (2021-2032) Figure 64. SAMEA Olaparib Revenue Share by Application (2021-2032) Figure 65. SAMEA Olaparib Sales Share by Application (2021-2032) Figure 66. SAMEA Olaparib Revenue Share by Country (2021-2032) Figure 67. SAMEA Olaparib Sales Share by Country (2021-2032) Figure 68. Olaparib Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Olaparib Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Tablets
  • Capsules
Applications
  • Ovarian Cancers
  • Prostate Cancers
  • Breast Cancers
  • Others
Companies covered
  • AstraZeneca
  • Everest Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Olaparib Market by Type
  3. 1.2.1 Global Olaparib Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Tablets
  5. 1.2.3 Capsules
  6. 1.3 Olaparib Market by Application
  7. 1.3.1 Global Olaparib Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Ovarian Cancers
  9. 1.3.3 Prostate Cancers
  10. 1.3.4 Breast Cancers
  11. 1.3.5 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Olaparib Market Dynamics
  1. 2.1 Olaparib Industry Trends
  2. 2.2 Olaparib Industry Drivers
  3. 2.3 Olaparib Industry Opportunities and Challenges
  4. 2.4 Olaparib Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Olaparib Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Olaparib Revenue by Region
  3. 3.2.1 Global Olaparib Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Olaparib Revenue by Region (2021-2026)
  5. 3.2.3 Global Olaparib Revenue by Region (2027-2032)
  6. 3.2.4 Global Olaparib Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Olaparib Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Olaparib Sales by Region
  9. 3.4.1 Global Olaparib Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Olaparib Sales by Region (2021-2026)
  11. 3.4.3 Global Olaparib Sales by Region (2027-2032)
  12. 3.4.4 Global Olaparib Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Olaparib Revenue by Manufacturers
  2. 4.1.1 Global Olaparib Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Olaparib Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Olaparib Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Olaparib Sales by Manufacturers
  6. 4.2.1 Global Olaparib Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Olaparib Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Olaparib Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Olaparib Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Olaparib Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Olaparib Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Olaparib Manufacturers, Product Type & Application
  13. 4.7 Global Olaparib Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Olaparib Market CR5 and HHI
  16. 4.8.2 2025 Olaparib Tier 1, Tier 2, and Tier 3
5 Olaparib Market by Type
  1. 5.1 Global Olaparib Revenue by Type
  2. 5.1.1 Global Olaparib Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Olaparib Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Olaparib Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Olaparib Sales by Type
  6. 5.2.1 Global Olaparib Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Olaparib Sales by Type (2021-2032) & (k pcs)
  8. 5.2.3 Global Olaparib Sales Market Share by Type (2021-2032)
  9. 5.3 Global Olaparib Price by Type
6 Olaparib Market by Application
  1. 6.1 Global Olaparib Revenue by Application
  2. 6.1.1 Global Olaparib Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Olaparib Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Olaparib Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Olaparib Sales by Application
  6. 6.2.1 Global Olaparib Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Olaparib Sales by Application (2021-2032) & (k pcs)
  8. 6.2.3 Global Olaparib Sales Market Share by Application (2021-2032)
  9. 6.3 Global Olaparib Price by Application
7 Company Profiles
  1. 7.1 AstraZeneca
  2. 7.1.1 AstraZeneca Company Information
  3. 7.1.2 AstraZeneca Business Overview
  4. 7.1.3 AstraZeneca Olaparib Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 AstraZeneca Olaparib Product Portfolio
  6. 7.1.5 AstraZeneca Recent Developments
  7. 7.2 Everest Pharmaceuticals
  8. 7.2.1 Everest Pharmaceuticals Company Information
  9. 7.2.2 Everest Pharmaceuticals Business Overview
  10. 7.2.3 Everest Pharmaceuticals Olaparib Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Everest Pharmaceuticals Olaparib Product Portfolio
  12. 7.2.5 Everest Pharmaceuticals Recent Developments
8 North America
  1. 8.1 North America Olaparib Market Size by Type
  2. 8.1.1 North America Olaparib Revenue by Type (2021-2032)
  3. 8.1.2 North America Olaparib Sales by Type (2021-2032)
  4. 8.1.3 North America Olaparib Price by Type (2021-2032)
  5. 8.2 North America Olaparib Market Size by Application
  6. 8.2.1 North America Olaparib Revenue by Application (2021-2032)
  7. 8.2.2 North America Olaparib Sales by Application (2021-2032)
  8. 8.2.3 North America Olaparib Price by Application (2021-2032)
  9. 8.3 North America Olaparib Market Size by Country
  10. 8.3.1 North America Olaparib Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Olaparib Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Olaparib Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Olaparib Market Size by Type
  2. 9.1.1 Europe Olaparib Revenue by Type (2021-2032)
  3. 9.1.2 Europe Olaparib Sales by Type (2021-2032)
  4. 9.1.3 Europe Olaparib Price by Type (2021-2032)
  5. 9.2 Europe Olaparib Market Size by Application
  6. 9.2.1 Europe Olaparib Revenue by Application (2021-2032)
  7. 9.2.2 Europe Olaparib Sales by Application (2021-2032)
  8. 9.2.3 Europe Olaparib Price by Application (2021-2032)
  9. 9.3 Europe Olaparib Market Size by Country
  10. 9.3.1 Europe Olaparib Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Olaparib Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Olaparib Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Olaparib Market Size by Type
  2. 10.1.1 China Olaparib Revenue by Type (2021-2032)
  3. 10.1.2 China Olaparib Sales by Type (2021-2032)
  4. 10.1.3 China Olaparib Price by Type (2021-2032)
  5. 10.2 China Olaparib Market Size by Application
  6. 10.2.1 China Olaparib Revenue by Application (2021-2032)
  7. 10.2.2 China Olaparib Sales by Application (2021-2032)
  8. 10.2.3 China Olaparib Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Olaparib Market Size by Type
  2. 11.1.1 Asia Olaparib Revenue by Type (2021-2032)
  3. 11.1.2 Asia Olaparib Sales by Type (2021-2032)
  4. 11.1.3 Asia Olaparib Price by Type (2021-2032)
  5. 11.2 Asia Olaparib Market Size by Application
  6. 11.2.1 Asia Olaparib Revenue by Application (2021-2032)
  7. 11.2.2 Asia Olaparib Sales by Application (2021-2032)
  8. 11.2.3 Asia Olaparib Price by Application (2021-2032)
  9. 11.3 Asia Olaparib Market Size by Country
  10. 11.3.1 Asia Olaparib Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Olaparib Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Olaparib Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Olaparib Market Size by Type
  2. 12.1.1 SAMEA Olaparib Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Olaparib Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Olaparib Price by Type (2021-2032)
  5. 12.2 SAMEA Olaparib Market Size by Application
  6. 12.2.1 SAMEA Olaparib Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Olaparib Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Olaparib Price by Application (2021-2032)
  9. 12.3 SAMEA Olaparib Market Size by Country
  10. 12.3.1 SAMEA Olaparib Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Olaparib Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Olaparib Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Olaparib Value Chain Analysis
  2. 13.1.1 Olaparib Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Olaparib Production Mode & Process
  6. 13.2 Olaparib Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Olaparib Distributors
  9. 13.2.3 Olaparib Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst